Erratum to: An epistaxis severity score for hereditary hemorrhagic telangiectasia: Epistaxis Severity Score for HHT (The Laryngoscope, (2010), 120, 4, (838-843), 10.1002/lary.20818);An epistaxis severity score for hereditary hemorrhagic telangiectasia

Laryngoscope

Volumn 120, Issue 4, 2010, Pages 838-843

  Hoag, Jeffrey B ^a   Terry, Peter ^b   Mitchell, Sally ^b   Reh, Douglas ^b   Merlo, Christian A ^b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Epistaxis; Hereditary hemorrhagic telangiectasia; Osler Rendu Weber severity score

Indexed keywords

ADULT; ANAMNESIS; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CLINICAL TRIAL; DISEASE DURATION; DISEASE SEVERITY; EPISTAXIS; EPISTAXIS SEVERITY SCORE; FEMALE; FREQUENCY ANALYSIS; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RENDU OSLER WEBER DISEASE; RISK FACTOR; SCORING SYSTEM; SELF REPORT;

EID: 77950813985     PISSN: 0023852X     EISSN: 15314995     Source Type: Journal    
DOI: 10.1002/lary.29919     Document Type: Erratum

References (15)

1. Westermann CJJ, Rosina AF, de Vries V, de Coteau PA. The prevalence and manifestations of hereditary hemorrhagic telangiectasia in the Afro-Caribbean population of the Netherlands Antilles: a family screening. Am J Med Genet A 2003;116:324-328. (Pubitemid 37063583)
2. Guttmacher AE, Marchuk DA, White RI Jr. Hereditary hemorrhagic telangiectasia. N Engl J Med 1995;333: 918-924.
3. Pasculli G, Resta F, Guastamacchia E, Di Gennaro L, Suppressa P, Sabba C. Health-related quality of life in a rare disease: hereditary hemorrhagic telangiectasia (HHT) or Rendu-Osler-Weber disease. Qual Life Res 2004;13: 1715-1723. (Pubitemid 41215251)
4. Lennox PA, Hitchings AE, Lund VJ, Howard DJ. The SF-36 health status questionnaire in assessing patients with epistaxis secondary to hereditary hemorrhagic telangiectasia. Am J Rhinol 2005;19:71-74.
5. Levine CG, Ross DA, Henderson KJ, Leder SB, White RI Jr. Long-term complications of septal dermoplasty in patients with hereditary hemorrhagic telangiectasia. Otolaryngol Head Neck Surg 2008;138:721-724. (Pubitemid 351707539)
6. Geisthoff UW, Heckmann K, D'Amelio R, et al. Healthrelated quality of life in hereditary hemorrhagic telangiectasia. Otolaryngol Head Neck Surg 2007;136:726-733. (Pubitemid 46660240)
7. Al-Deen S, Bachmann-Harildstad G. A grading scale for epistaxis in hereditary haemorrhagic telangiectasia. Rhinology 2008;46:281-284.
8. Faughnan ME, Palda VA, Garcia-Tsao G, et al. International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic Telangiectasia. J Med Genet. In press.
9. Shovlin CL, Guttmacher AE, Buscarini E, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber Syndrome). Am J Med Genet 2000; 91:66-67. (Pubitemid 30127562)
10. Efron B. Bootstrap methods: another look at the jackknife. Ann Stat 1979;7:1-26.
11. Lorig KR, Sobel DS, Stewart AL, et al. Evidence suggesting that a chronic disease self-management program can improve health status while reducing hospitalization: a randomized control trial. Med Care 1999;37:5-14.
12. Institute of Healthcare Improvement. Partnering with patients and families to design a patient- and family-centered health care system: recommendations and promising practices (April 2008). Available at: www.IHI.ORG. Accessed October 1, 2008.
13. Van Gent MWF, Post MC, Mager JJ, et al. Diagnostic Curacao criteria for HHT; are they still valid? Haematol Meet Rep 2009;3;C13-C25.
14. United Network for Organ Sharing. Lung transplantation allocation score. Available at: www.unos.org/resources/frm-LAS-Calculator.asp. Accessed August 20, 2009.
15. Mahoney EJ, Shapshay SM. New classification of nasal vasculature patterns in hereditary hemorrhagic telangiectasia. Am J Rhinol 2006;20:87-90.